NEUROGENOMICS CORE
神经基因组学核心
基本信息
- 批准号:10669066
- 负责人:
- 金额:$ 8.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-23 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAddressAdvisory CommitteesAnimal ModelAnimalsApplications GrantsArchitectureAreaAwardBehavior DisordersBioinformaticsBiologicalBiological AssayBiomedical ResearchCancer CenterCell LineCellsChromatinComplementComplexComputer AnalysisConsultationsDNADNA Modification ProcessDNA SequenceDNA analysisDataData AnalysesDiagnosisDiseaseEnsureEvaluationFamiliarityFeasibility StudiesFoundationsFundingFutureGene ExpressionGenesGeneticGenomicsGenotypeGoalsGrantHigh Performance ComputingHumanHuman GeneticsHuman ResourcesIndividualIntellectual and Developmental Disabilities Research CentersIntellectual functioning disabilityInvestigationMeasuresMethylationModelingNeurosciencesNucleic Acid Regulatory SequencesPatientsPharmaceutical PreparationsPilot ProjectsPopulation GeneticsPostdoctoral FellowProcessQuality ControlRNARNA SequencesResearchResearch DesignResearch PersonnelRoleServicesSolidStructureTechnologyTimeTissuesTrainingVariantautism spectrum disorderbrain malformationcollegecomputerized data processingcostcost effectivedesignepigenomeepigenomicsexomeexome sequencingexperienceexperimental studyflexibilityfunctional genomicsgenome sequencinggenome-widegenomic datahuman subjectimprovedinduced pluripotent stem cellinnovationinnovative technologiesinterestlarge datasetsmembernerve stem cellneurogenomicsnew technologynext generation sequencingoperationprogramssecondary analysissingle cell technologysingle-cell RNA sequencingskillsstudent trainingtranscriptomicsvoucherwhole genome
项目摘要
PROJECT SUMMARY/ABSTRACT – NEUROGENOMICS CORE
Neurogenomics research, including analysis of DNA, RNA and the epigenome, consisting of investigation of
chromatin and methylation, is increasingly important in studies of intellectual and developmental disabilities
(IDDs). For example, neurogenomics analysis can identify the cause of human IDDs as well as determine the
mechanism by which genes are regulated in animal or cell-based models. The Neurogenomics (NGEN) Core
provides standard and innovative genomic assays that range from genotyping of DNA variants in human
subjects through single cell RNA-sequencing or evaluation of accessible chromatin in neural progenitor cells.
The NCEI with the NGEN Core will establish spatial transcriptomic technology, making it possible to investigate
gene expression in the context of tissue architecture. Further, the NGEN Core provides computational and
bioinformatic analysis of large datasets that emerge from next-generation sequencing (NGS) experiments and
will train students and postdoctoral fellows. The NGEN core is flexible to relinquish old services that are no
longer utilized or cost effective, to implement innovative services that will enhance IDD research and discovery.
The team consists of a Director and Associate Director with complementary expertise in human genetics,
functional genomics and epigenomics. The Operations Directors have hands-on roles in implementing and
establishing new technologies or bioinformatic services that are performed by senior technical staff. The
NGEN Core has an advisory committee needed to ensure optimal service and to help decide which services to
offer in the Core. The NGEN Core Components are part of established shared facilities at Einstein that also
has oversite from the Cancer Center and College. One of the challenges in performing genomics research is
how to choose among many different assays that are available. The NGEN Core provides guidance to IDDRC
investigators in a prioritized manner, from study design, to experimental optimization to bioinformatic analysis.
For this, the Directors meet with individual investigators to provide guidance in helping to choose assays that
are best suited for their particular research question. Members of the IDDRC will receive prioritized access to
NGEN Core services and personalized consultation. The IDDRC Pilot Award and Voucher program is also
available through the ADM Core on a competitive basis, making it possible for investigators to initiate
neurogenomics projects even if current grant funding is limited. Through this facilitated availability of a wide
range of services and innovative technologies involving critical aspects of genomic analysis, the NGEN core is
an essential component of the IDDRC.
项目摘要/摘要-神经基因组学核心
神经基因组学研究,包括DNA、RNA和表观基因组的分析,包括对
染色质和甲基化在智力和发育障碍的研究中越来越重要
(IDDS)。例如,神经基因组分析可以确定人类IDDS的原因,并确定
在动物或基于细胞的模型中,基因被调控的机制。神经基因组学(NGEN)核心
提供标准和创新的基因组分析,范围从人类DNA变异的基因分型
受试者通过单细胞RNA测序或评估神经前体细胞中可获得的染色质。
拥有Ngen Core的NCEI将建立空间转录技术,使研究成为可能
组织架构背景下的基因表达。此外,下一代核心提供了计算和
对来自下一代测序(NGS)实验和
将培养学生和博士后研究员。下一代核心是灵活的,可以放弃不是
更长时间使用或更具成本效益,以实施创新服务,以加强IDD研究和发现。
该团队由一名主任和副主任组成,他们在人类遗传学方面具有互补的专业知识,
功能基因组学和表观基因组学。运营总监在实施和
建立由高级技术人员执行的新技术或生物信息服务。这个
Ngen Core有一个咨询委员会,以确保最佳服务并帮助决定将哪些服务
核心要约。Ngen Core组件是爱因斯坦已建立的共享设施的一部分,该设施还
有来自癌症中心和学院的网站。进行基因组学研究的挑战之一是
如何在许多不同的可用化验方法中进行选择。NGEN核心为IDDRC提供指导
从研究设计到实验优化,再到生物信息学分析,研究人员以优先顺序进行研究。
为此,董事与个别调查人员会面,以提供指导,帮助选择
最适合他们特定的研究问题。IDDRC的成员将获得优先访问
NGEN核心服务和个性化咨询。IDDRC飞行员奖和代金券计划也是
在竞争的基础上通过ADM核心提供,使调查人员能够启动
神经基因组学项目,即使目前的赠款资金有限。通过这一便利的广泛的可用
涉及基因组分析关键方面的一系列服务和创新技术,ngen的核心是
国际发展与发展中心的一个重要组成部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BERNICE E MORROW其他文献
BERNICE E MORROW的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BERNICE E MORROW', 18)}}的其他基金
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10621288 - 财政年份:2022
- 资助金额:
$ 8.55万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10373375 - 财政年份:2022
- 资助金额:
$ 8.55万 - 项目类别:
Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome
22q11.2缺失综合征先天性心脏病的遗传修饰
- 批准号:
10553279 - 财政年份:2022
- 资助金额:
$ 8.55万 - 项目类别:
Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells
神经嵴和第二心野细胞介导先天性心脏病的分子发病机制
- 批准号:
10435713 - 财政年份:2022
- 资助金额:
$ 8.55万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10289982 - 财政年份:2021
- 资助金额:
$ 8.55万 - 项目类别:
Molecular and cellular mechanisms in cardiac outflow tract formation and defects
心脏流出道形成和缺陷的分子和细胞机制
- 批准号:
10471433 - 财政年份:2021
- 资助金额:
$ 8.55万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10615781 - 财政年份:2020
- 资助金额:
$ 8.55万 - 项目类别:
Cell fate choices by Tbx1 in forming the mammalian heart
Tbx1 在形成哺乳动物心脏过程中的细胞命运选择
- 批准号:
10242828 - 财政年份:2020
- 资助金额:
$ 8.55万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 8.55万 - 项目类别:
Research Grant